5ZHAO Wenhui, Katzmarzyk P T, Horswell R, et al. Body Mass Index and the Risk of All-Cause Mortality among Patients with Type 2 Diabetes [J]. Circulation, 2014, 130(4): 2143-2151.
6Wild S, Roglic G, Green A, et al. Global Prevalence of Diabetes: Estimate for the Year 2000 and Projections for 2030 [J]. Diabetes Care, 2004, 27(5) : 1047-1053.
7Costantino L, Rastelli G, Vianello P. Diabetes Complications and Their Potential Prevention: Aldose Reductase Inhibition and Other Approaches [J]. Med Res Rev, 1999, 19(1): 3-23.
8Matsumoto T, Ono Y, Kuromiya A, et al. Long-Term Treatment with Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats [J]. J Pharmacol Sci, 2008, 107(3) : 340-348.
9Dunlop M. Aldose Reductase and the Role of the Polyol Pathway in Diabetic Nephropathy [J]. Kidney International, 2000, 58(77): 3-12.
